Clinical Trial Update: Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women [EARLY_Phase 1]

View source ↗

Summary

Early-phase safety and pharmacokinetic study of antiretroviral intravaginal rings for HIV prophylaxis in healthy women has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Antiretroviral intravaginal rings

Snippet

Sponsor: Auritec Pharmaceuticals | Conditions: Human Immunodeficiency Virus (HIV) Prophylaxis | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-07-02